SSSW(SH:688399) Sou Hu Cai Jing·2025-08-19 17:17Group 1 - The core viewpoint of the news is that Shuoshi Biotechnology (688399) has experienced a decline in stock price and significant net outflow of funds, alongside a decrease in revenue and profit in its latest financial report [1][3] - As of August 19, 2025, the stock closed at 65.06 yuan, down 1.03%, with a turnover rate of 2.64% and a trading volume of 22,100 hands, amounting to 143 million yuan in transaction value [1] - The company reported total revenue of 176 million yuan for the first half of 2025, a year-on-year decrease of 1.05%, and a net profit attributable to shareholders of 3.99 million yuan, down 86.35% year-on-year [1] Group 2 - The company has a current ratio of 4.181, a quick ratio of 4.078, and a debt-to-asset ratio of 16.13%, indicating a strong liquidity position [1] - Shuoshi Biotechnology has made investments in 15 companies and participated in 1,760 bidding projects, showcasing its active engagement in the market [2] - The company holds 209 trademark registrations and 180 patents, along with 244 administrative licenses, reflecting its focus on intellectual property and regulatory compliance [2]